nodes	percent_of_prediction	percent_of_DWPC	metapath
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—NF1—peripheral nervous system neoplasm	0.135	0.193	CbGpPWpGaD
Tyloxapol—LPL—trigeminal ganglion—peripheral nervous system neoplasm	0.0923	0.306	CbGeAlD
Tyloxapol—LPL—parotid gland—peripheral nervous system neoplasm	0.087	0.289	CbGeAlD
Tyloxapol—LPL—Alzheimers Disease—PPP3R1—peripheral nervous system neoplasm	0.0842	0.121	CbGpPWpGaD
Tyloxapol—LPL—brainstem—peripheral nervous system neoplasm	0.0817	0.271	CbGeAlD
Tyloxapol—LPL—cerebellum—peripheral nervous system neoplasm	0.0403	0.134	CbGeAlD
Tyloxapol—LPL—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.0351	0.0503	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.0343	0.0491	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	0.0305	0.0436	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	0.0284	0.0406	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—CASP3—peripheral nervous system neoplasm	0.0236	0.0338	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.0226	0.0324	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	0.0223	0.0319	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.0172	0.0246	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.0153	0.0219	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—TP53—peripheral nervous system neoplasm	0.0151	0.0216	CbGpPWpGaD
Tyloxapol—LPL—SREBP signalling—AKT1—peripheral nervous system neoplasm	0.0142	0.0204	CbGpPWpGaD
Tyloxapol—LPL—Disease—GNS—peripheral nervous system neoplasm	0.0132	0.0189	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.0127	0.0182	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GNS—peripheral nervous system neoplasm	0.0111	0.0158	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—NME1—peripheral nervous system neoplasm	0.0106	0.0152	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—COX2—peripheral nervous system neoplasm	0.0102	0.0146	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.00924	0.0132	CbGpPWpGaD
Tyloxapol—LPL—Disease—PPP3R1—peripheral nervous system neoplasm	0.00923	0.0132	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.00886	0.0127	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—MET—peripheral nervous system neoplasm	0.0082	0.0117	CbGpPWpGaD
Tyloxapol—LPL—Disease—ENO2—peripheral nervous system neoplasm	0.00799	0.0114	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.00759	0.0109	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.007	0.01	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ENO2—peripheral nervous system neoplasm	0.00669	0.00958	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.00646	0.00925	CbGpPWpGaD
Tyloxapol—LPL—Disease—SLC2A1—peripheral nervous system neoplasm	0.00644	0.00922	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.006	0.00858	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—BCHE—peripheral nervous system neoplasm	0.00566	0.0081	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.0054	0.00772	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—TH—peripheral nervous system neoplasm	0.00532	0.00761	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.00485	0.00695	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.00456	0.00653	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GNAS—peripheral nervous system neoplasm	0.00434	0.00621	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ABCB1—peripheral nervous system neoplasm	0.00426	0.0061	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.00415	0.00594	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.00396	0.00566	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.00363	0.0052	CbGpPWpGaD
Tyloxapol—LPL—Disease—PTPN11—peripheral nervous system neoplasm	0.0036	0.00516	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—HRAS—peripheral nervous system neoplasm	0.00334	0.00478	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—AKT1—peripheral nervous system neoplasm	0.00295	0.00422	CbGpPWpGaD
Tyloxapol—LPL—Disease—ERBB2—peripheral nervous system neoplasm	0.00285	0.00407	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.00252	0.00361	CbGpPWpGaD
Tyloxapol—LPL—Disease—NRAS—peripheral nervous system neoplasm	0.00217	0.0031	CbGpPWpGaD
Tyloxapol—LPL—Disease—MYC—peripheral nervous system neoplasm	0.00202	0.00289	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.00199	0.00285	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.00181	0.00259	CbGpPWpGaD
Tyloxapol—LPL—Disease—HRAS—peripheral nervous system neoplasm	0.00158	0.00227	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.00152	0.00217	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MYC—peripheral nervous system neoplasm	0.00141	0.00202	CbGpPWpGaD
Tyloxapol—LPL—Disease—AKT1—peripheral nervous system neoplasm	0.0014	0.002	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—AKT1—peripheral nervous system neoplasm	0.00117	0.00168	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TP53—peripheral nervous system neoplasm	0.00116	0.00166	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HRAS—peripheral nervous system neoplasm	0.00111	0.00159	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—AKT1—peripheral nervous system neoplasm	0.00098	0.0014	CbGpPWpGaD
